secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75496 grounded facts newest July 17, 2026, 5:30 PM ET RSS · JSON

Showing 9651–9700 of 18437

Departed

Michael Kaswan

Chief Financial Officer
OBIO · Orchestra BioMed Holdings, Inc.
Effective
2023-06-06
Successor
Andrew Taylor
Filed
June 8, 2023, 7:59 PM ET
Mr. Michael Kaswan, the Company’s Chief Financial Officer, mutually agreed to terms pursuant to which Mr. Kaswan will step down as the Company’s Chief Financial Officer and separate from employment effective as of June 6, 2023
Departed

Murray Kessler

President and Chief Executive Officer
PRGO · PERRIGO Co plc
Effective
2023-06-30
Successor
Patrick Lockwood-Taylor
Filed
June 8, 2023, 7:59 PM ET
following the retirement of Murray Kessler from those same positions on the same day
Appointed

Patrick Lockwood-Taylor

President and Chief Executive Officer
PRGO · PERRIGO Co plc
Effective
2023-06-30
Filed
June 8, 2023, 7:59 PM ET
announced the appointment of Mr. Patrick Lockwood-Taylor, 54, as President, CEO and director, effective June 30, 2023
Departed

Tiffany Mason

Chief Financial Officer
DRVN · Driven Brands Holdings Inc.
Effective
2023-05-04
Filed
June 8, 2023, 7:59 PM ET
Ms. Mason’s employment with the Company ended on May 4, 2023, which the Compensation Committee of the Company’s Board of Directors determined was a termination without cause under her employment agreement with the Company.
Departed

Tom O'Neil

Chief Financial Officer
Satsuma Pharmaceuticals, Inc.
Effective
2023-06-08
Filed
June 8, 2023, 7:59 PM ET
Tom O'Neil ceased serving as Chief Financial Officer of the Company
Departed

John Kollins

President and Chief Executive Officer
Satsuma Pharmaceuticals, Inc.
Effective
2023-06-08
Filed
June 8, 2023, 7:59 PM ET
John Kollins ceased serving as President and Chief Executive Officer of the Company
Appointed

Jeffrey M. Canouse

Chief Executive Officer and Director
Friendable, Inc.
Effective
2023-05-19
Filed
June 8, 2023, 7:59 PM ET
Effective May 19, 2023, our Board of Directors, approved the appointment of Jeffrey M. Canouse as Chief Executive Officer and Director.
Departed

Matt Aune

Chief Financial Officer
PHUN · Phunware, Inc.
Effective
2023-06-02
Filed
June 8, 2023, 7:59 PM ET
Matt Aune would be leaving his role as Chief Financial Officer, effective as of June 2, 2023
Departed

Richard Brounstein

Chief Financial Officer
BEAT · HeartBeam, Inc.
Effective
2023-10-31
Filed
June 8, 2023, 7:59 PM ET
Additionally, Mr. Brounstein, the Company’s Chief Financial Officer, announced plans to retire and his resignation will be effective October 31, 2023.
Departed

Michael Wittmeyer

Chief Executive Officer of JM Bullion, Inc.
GOLD · Gold.com, Inc.
Effective
2023-07-01
Filed
June 7, 2023, 7:59 PM ET
On June 5, 2023, Michael Wittmeyer notified A-Mark Precious Metals, Inc. ("A-Mark" or the "Company") of his intention to resign as Chief Executive Officer of JM Bullion, Inc. ("JMB"), a wholly owned subsidiary of A-Mark, effective July 1, 2023
Role change (interim)

Brian Shea

Interim Chief Executive Officer and President
Oncorus, Inc.
Effective
2023-06-06
Filed
June 7, 2023, 7:59 PM ET
the Board appointed Brian Shea, age 35, the Company's General Counsel and Secretary, as the Company's Interim Chief Executive Officer and President.
Appointed

Fred Cooper

Chief Executive Officer, President, and Chairman
KWIK · KwikClick, Inc.
Effective
2023-05-31
Filed
June 7, 2023, 7:59 PM ET
On May 31, 2023 during a meeting of the Board of Directors, Fred Cooper, a major shareholder of KwikClick, Inc., was nominated, unanimously approved, and appointed to serve as the Chairman of the Board of Directors of the Company.
Departed

Dr. Lance Zhou

Chief Executive Officer
PEVM · PHOENIX MOTOR INC.
Effective
2023-06-06
Successor
Xiaofeng Peng
Filed
June 7, 2023, 7:59 PM ET
On June 6, 2023, the Board of Directors of Phoenix Motor Inc., a Delaware corporation (the “Company”), appointed its Chairman, Xiaofeng Peng to replace Dr. Lance Zhou as the Company’s Chief Executive Officer effective immediately.
Appointed

Xiaofeng Peng

Chief Executive Officer
PEVM · PHOENIX MOTOR INC.
Effective
2023-06-06
Filed
June 7, 2023, 7:59 PM ET
On June 6, 2023, the Board of Directors of Phoenix Motor Inc., a Delaware corporation (the “Company”), appointed its Chairman, Xiaofeng Peng to replace Dr. Lance Zhou as the Company’s Chief Executive Officer effective immediately.
Departed

Claudia Drayton

Chief Financial Officer and Treasurer
QSI · Quantum-Si Inc
Effective
2023-05-12
Filed
June 7, 2023, 7:59 PM ET
Ms. Drayton stepped down as Chief Financial Officer and Treasurer of the Company on May 12, 2023
Departed

Matthew Furlong

President and Chief Executive Officer
GME · GameStop Corp.
Effective
2023-06-05
Filed
June 7, 2023, 7:59 PM ET
On June 5, 2023, the Board of Directors (the “ Board ”) of the Company terminated Matthew Furlong as President and Chief Executive Officer of the Company, effective immediately
Appointed

Sandra Pennell

Senior Vice President of Finance and principal financial and accounting officer
DCTH · DELCATH SYSTEMS, INC.
Effective
2023-06-01
Filed
June 7, 2023, 7:59 PM ET
On June 1, 2023, and effective as of the date thereof, Delcath Systems, Inc. (the “Company”) appointed Sandra Pennell as Senior Vice President of Finance and principal financial and accounting officer of the Company.
Departed

Amit Joshi

Chief Financial Officer
Apollo Debt Solutions BDC
Filed
June 7, 2023, 7:59 PM ET
On June 2, 2023, Amit Joshi, Chief Financial Officer of Apollo Debt Solutions BDC (the “Company”), notified the Company of his intention to resign.
Appointed

Eduardo A. Brito

President, Chief Executive Officer and Secretary
ASII · Accredited Solutions, Inc.
Effective
2023-06-01
Filed
June 7, 2023, 7:59 PM ET
Mr. Brito was appointed as President, Chief Executive Officer and Secretary of the Company.
Departed (interim)

Douglas V. Martin

Interim Chief Executive Officer
ASII · Accredited Solutions, Inc.
Effective
2023-06-01
Successor
Eduardo A. Brito
Filed
June 7, 2023, 7:59 PM ET
Douglas V. Martin (“Martin”) resigned as the Company’s Interim CEO.
Appointed

Surendra Ajjarapu

Chief Executive Officer
TVGN · Tevogen Bio Holdings Inc.
Effective
2023-06-07
Filed
June 7, 2023, 7:59 PM ET
Surendra Ajjarapu and Francis Knuettel II were appointed as the Company’s Chief Executive Officer and Chairman and Chief Financial Officer, respectively
Appointed

Francis Knuettel II

Chief Financial Officer
TVGN · Tevogen Bio Holdings Inc.
Effective
2023-06-07
Filed
June 7, 2023, 7:59 PM ET
Surendra Ajjarapu and Francis Knuettel II were appointed as the Company’s Chief Executive Officer and Chairman and Chief Financial Officer, respectively
Appointed

Keith Siegner

Executive Vice President and Chief Financial Officer
LOVE · Lovesac Co
Effective
2023-06-30
Filed
June 7, 2023, 7:59 PM ET
On June 1, 2023, the Board of Directors (the “Board”) of the Company appointed Mr. Keith Siegner to serve as Executive Vice President and Chief Financial Officer of the Company, effective June 30, 2023.
Departed

Donna Dellomo

Chief Financial Officer
LOVE · Lovesac Co
Effective
2023-06-30
Successor
Keith Siegner
Filed
June 7, 2023, 7:59 PM ET
On June 1, 2023, Ms. Donna Dellomo, the Chief Financial Officer, principal accounting officer, Secretary and Treasurer of The Lovesac Company (the “Company”) informed the Company that she will resign from her role effective June 30, 2023.
Appointed

Miles Jennings

Chief Executive Officer
NIXX · Nixxy, Inc.
Filed
June 7, 2023, 7:59 PM ET
On June 2, 2022, the Board appointed Miles Jennings, age 45, a current Board member, to serve as the Chief Executive Officer.
Departed

Long Ding Jung

Chief Executive Officer
Leet Technology Inc.
Effective
2023-06-01
Successor
Song Dai
Filed
June 7, 2023, 7:59 PM ET
Effective June 1, 2023, Mr. Long Ding Jung resigned as a Chief Executive Officer of Leet Technology Inc. (the “Company”).
Appointed (interim)

Song Dai

Chief Executive Officer
Leet Technology Inc.
Effective
2023-06-07
Filed
June 7, 2023, 7:59 PM ET
Effective June 7, 2023, the board of directors (the “Board”) appointed Mr. Song Dai who has been a director of the Company since October 23, 2020, as the Company’s interim Chief Executive Officer.
Role change

Thomas Ernst

Chief Financial Officer and Treasurer
SYM · Symbotic Inc.
Effective
2023-06-05
Filed
June 7, 2023, 7:59 PM ET
Thomas Ernst, the Company's Chief Financial Officer and Treasurer, assumed the responsibilities of chief accounting officer effective as of June 5, 2023
Departed

Sameer Ralhan

Senior Vice President
CC · Chemours Co
Effective
2023-06-19
Successor
Jonathan Lock
Filed
June 6, 2023, 7:59 PM ET
Sameer Ralhan, Senior Vice President of The Chemours Company (the “Company”), notified the Company of his intention to resign, effective June 19, 2023.
Appointed

Jonathan Lock

Senior Vice President, Chief Financial Officer
CC · Chemours Co
Effective
2023-06-06
Filed
June 6, 2023, 7:59 PM ET
Jonathan Lock, Senior Vice President, Chief Development Officer is appointed Senior Vice President, Chief Financial Officer, effective June 6, 2023.
Appointed

Kevin Kraus

Chief Financial Officer
EGHT · 8X8 INC /DE/
Effective
2023-06-05
Filed
June 6, 2023, 7:59 PM ET
On June 5, 2023, the Board appointed Mr. Kraus as permanent Chief Financial Officer (“ CFO ”) of the Company.
Appointed (interim)

Diana P. Diaz

interim Chief Financial Officer
DRCT · Direct Digital Holdings, Inc.
Effective
2023-06-05
Filed
June 6, 2023, 7:59 PM ET
the Board of Directors (the “ Board ”) of the Company appointed Diana P. Diaz as interim Chief Financial Officer.
Departed

Susan Echard

Chief Financial Officer
DRCT · Direct Digital Holdings, Inc.
Effective
2023-06-05
Successor
Diana P. Diaz
Filed
June 6, 2023, 7:59 PM ET
On June 5, 2023, the Company announced that Susan Echard, the Company’s Chief Financial Officer, has separated from the Company, effective immediately.
Appointed (interim)

Gene Jones

Interim Chief Financial Officer
RVYL · RYVYL Inc.
Effective
2023-06-01
Filed
June 6, 2023, 7:59 PM ET
appointed Gene Jones as the Company’s Interim Chief Financial Officer, effective as of June 1, 2023
Departed

Mary Lay Hoitt

Chief Financial Officer
RVYL · RYVYL Inc.
Effective
2023-06-01
Successor
Gene Jones
Filed
June 6, 2023, 7:59 PM ET
replacing Mary Lay Hoitt who left the Company on the same day.
Role change (interim)

Scott Anderson

Interim Chief Executive Officer
CHRW · C. H. ROBINSON WORLDWIDE, INC.
Effective
2023-06-25
Successor
David P. Bozeman
Filed
June 6, 2023, 7:59 PM ET
Mr. Anderson’s term as Interim CEO will end at the end of the day on June 25, 2023 and he will remain on the Board.
Appointed

David P. Bozeman

President and Chief Executive Officer
CHRW · C. H. ROBINSON WORLDWIDE, INC.
Effective
2023-06-26
Filed
June 6, 2023, 7:59 PM ET
On June 6, 2023, C.H. Robinson Worldwide, Inc. (the “Company”) announced that its Board of Directors (the “Board”) appointed David P. Bozeman as President and Chief Executive Officer (“CEO”) and a director of the Company, effective June 26, 2023.
Departed

Christine Zhao

Chief Financial Officer
ALTI · AlTi Global, Inc.
Effective
2023-06-15
Successor
Reid Parmelee
Filed
June 6, 2023, 7:59 PM ET
On June 1, 2023, AlTi Global, Inc. (the “Company”) announced the resignation of Christine Zhao as Chief Financial Officer of the Company.
Appointed (interim)

Reid Parmelee

interim Chief Financial Officer
ALTI · AlTi Global, Inc.
Filed
June 6, 2023, 7:59 PM ET
The Company also announced that Reid Parmelee, the Company’s Global Controller, has been appointed interim Chief Financial Officer.
Appointed (interim)

Eliot M. Lurier

Interim Chief Financial Officer
SomaLogic, Inc.
Effective
2023-06-06
Filed
June 6, 2023, 7:59 PM ET
Effective as of June 6, 2023, the Company appointed Eliot M. Lurier as its Interim Chief Financial Officer.
Departed

Shaun Blakeman

Chief Financial Officer
SomaLogic, Inc.
Effective
2023-06-05
Successor
Eliot M. Lurier
Filed
June 6, 2023, 7:59 PM ET
On June 5, 2023, SomaLogic, Inc. (the “Company”) and Shaun Blakeman, the Company’s Chief Financial Officer, agreed that Mr. Blakeman will no longer serve as the Company’s Chief Financial Officer.
Departed

Don Smith

Chief Financial Officer
SFCX · SUPA Consolidated Inc.
Effective
2023-05-31
Filed
June 6, 2023, 7:59 PM ET
Effective as of May 31, 2023, Don Smith, the Chief Financial Officer (principal financial and accounting officer) of Tribal Rides International Corp., a Nevada corporation, resigned.
Departed

Michael Angel

Chief Financial Officer
CXAI · CXApp Inc.
Effective
2023-06-05
Successor
Khurram P. Sheikh
Filed
June 6, 2023, 7:59 PM ET
On May 31, 2023, Michael Angel provided formal notice of his resignation as Chief Financial Officer of CXApp Inc.
Appointed (interim)

Khurram P. Sheikh

Interim Chief Financial Officer
CXAI · CXApp Inc.
Effective
2023-06-05
Filed
June 6, 2023, 7:59 PM ET
The Board of Directors of the Company approved, effective as of June 5, 2023, the appointment of Khurram P. Sheikh, the current Chief Executive Officer, as Interim Chief Financial Officer of the Company.
Appointed

Harry Leider

Chief Executive Officer
ZEOX · Zeo ScientifiX, Inc.
Effective
2023-06-06
Filed
June 6, 2023, 7:59 PM ET
On June 6, 2023, our board of directors appointed Harry Leider, M.D., M.B.A., as Chief Executive Officer and a member of the board of directors
Appointed

James L. Cunniff

Chief Executive Officer and President
ELMD · Electromed, Inc.
Effective
2023-07-01
Filed
June 5, 2023, 7:59 PM ET
On June 5, 2023, Electromed, Inc. (the "Company") announced the appointment of James L. Cunniff to serve as its next Chief Executive Officer and President, beginning July 1, 2023.
Departed

Steve Ward

Chief Financial Officer
Viscogliosi Brothers Acquisition Corp
Effective
2023-06-15
Filed
June 5, 2023, 7:59 PM ET
On May 30, 2023, Steve Ward notified the board of directors of Viscogliosi Brothers Acquisition Corp. (the “ Company ”) that he has resigned from his position as Chief Financial Officer the Company, effective June 15, 2023.
Departed

Dale Pfost

Chief Executive Officer
CMMB · Chemomab Therapeutics Ltd.
Effective
2023-06-01
Successor
Adi Mor
Filed
June 5, 2023, 7:59 PM ET
In connection with his replacement as Chief Executive Officer, on June 1, 2023, Dr. Dale Pfost agreed to step down from his position on the Board, including in his capacity as Chairman of the Board, effective as of the same date.
Appointed

Adi Mor

Chief Executive Officer
CMMB · Chemomab Therapeutics Ltd.
Effective
2023-06-01
Successor
Dale Pfost
Filed
June 5, 2023, 7:59 PM ET
appointed Dr. Adi Mor, co-founder of the Company, a current class III member of the Board and the Company's Chief Scientific Officer, as Chief Executive Officer of the Company to replace Dr. Dale Pfost, effective as of the same date.
Appointed

Sigal Fattal

Chief Financial Officer
CMMB · Chemomab Therapeutics Ltd.
Effective
2023-06-01
Successor
Donald Marvin
Filed
June 5, 2023, 7:59 PM ET
the Board appointed Ms. Sigal Fattal, the VP of Finance of the Company, as the Chief Financial Officer of the Company to replace Mr. Donald Marvin, effective as of the same date.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.